Skip to content

Evaluation of the effectiveness of L-citrulline plus nCPAP versus solitary nCPAP in improvement of endothelium dysfunction and decreasing the severity of obstructive sleep apnea

evaluation of the effectiveness of L-citrulline plus nCPAP versus solitary nCPAP in improvement of endothelium dysfunction and decreasing the severity of obstructive sleep apnea in patients undergoing polysomnography in Baharloo hospital and are categoriazed as moderate to serevere OSA

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181126041757N1
Enrollment
42
Registered
2019-04-18
Start date
2019-05-05
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea/L-citruline effect on artery. Obstructive sleep apnea (adult) (pediatric)

Interventions

Intervention 1: Intervention group: patients are divided into 2 groups by block randomization and by stratification protocol we try that the diabetes dispersion be the same in both groups. For our int

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are categorized as moderate to severe according to AHI criteria by using polysomnography The ones that clinical ultrasonography proves that the patient has endothelial dysfunction (FMD> NMD) Patients the their arterial muscular dysfunction has been ruled out

Exclusion criteria

Exclusion criteria: If less than 40 days have been passed from patien's OSA treatment Hx of coronary artery disease (>50% of arterial occlusion, or any background PCI or CBAG) Ischemic heart disease Smoking Patients who do not have endothelial dysfunction (FMD ratio to normal vessel diameter is more than one) Receiving any medication that affects endothelial function unless 4 half-life of the drug has been passed since its last consume.

Design outcomes

Primary

MeasureTime frame
Brachial artery diameter. Timepoint: The beginning and the end of the study. Method of measurement: colour doppler ultrasound.

Secondary

MeasureTime frame
Daily sleepiness. Timepoint: at the beginning and the end of the study. Method of measurement: Epworth sleepness scale questionnaire.;Depression rate. Timepoint: The beginning and the end of the study. Method of measurement: patients health questionnaire-9.;Dislipidemia. Timepoint: The beginning and the end of the study. Method of measurement: Patient case.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Nateghi

Tehran University of Medical Sciences

snateghi@sina.tums.ac.ir+98 21 5517 6031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026